Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B | Zendy

Ørjan Samuelsen | Zendy; Hanne H. Haukland | Zendy; Barbara C. Kahl | Zendy; Christof von Eiff | Zendy; Richard A. Proctor | Zendy; Hilde Ulvatne | Zendy; Kjersti Sandvik | Zendy; Lars H. Vorland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B

Author(s) -

Ørjan Samuelsen,

Hanne H. Haukland,

Barbara C. Kahl,

Christof von Eiff,

Richard A. Proctor,

Hilde Ulvatne,

Kjersti Sandvik,

Lars H. Vorland

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki385

Subject(s) - microbiology and biotechnology , biology , lysostaphin , staphylococcus aureus , menadione , auxotrophy , peptide , antimicrobial , mutant , bacteria , biochemistry , gene , genetics , enzyme

To determine whether Staphylococcus aureus small colony variants (SCVs) are resistant to the antimicrobial peptide lactoferricin B. To assess if deficiency in transmembrane potential, a common characteristic of SCVs that are haemin- or menadione-auxotrophs, affects the uptake of the peptide into the bacterial cytoplasm.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research